These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16368466)

  • 1. Menopausal hormone therapy (HT) in patients with breast cancer.
    Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
    Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
    von Schoultz E; Rutqvist LE;
    J Natl Cancer Inst; 2005 Apr; 97(7):533-5. PubMed ID: 15812079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
    La Vecchia C
    Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
    Garwood ER; Kumar AS; Shim V
    Ann Surg Oncol; 2008 Sep; 15(9):2526-32. PubMed ID: 18618187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
    Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
    Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy for women after breast cancer: a review.
    Levgur M
    J Reprod Med; 2004 Jul; 49(7):510-26. PubMed ID: 15305822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 12. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2003 Mar; 6(1):45-52. PubMed ID: 12725664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
    Peeyananjarassri K; Baber R
    Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are older breast carcinoma survivors willing to take hormone replacement therapy?
    Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
    Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
    Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
    Harefuah; 2002 Nov; 141(11):994-6, 1008. PubMed ID: 12476637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in breast cancer patients and survivors.
    Del Priore G; Hatami M
    Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and treatment in cancer therapy-induced early menopause.
    Boekhout AH; Beijnen JH; Schellens JH
    Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and breast cancer.
    Zimmerman VL; Smeltzer SC
    Clin Excell Nurse Pract; 2000 Jan; 4(1):30-4. PubMed ID: 11858293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.